HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interventional oncology: new options for interstitial treatments and intravascular approaches: right hepatic vein embolization after right portal vein embolization for inducing hypertrophy of the future liver remnant.

Abstract
Extensive hepatic resection is often associated with post-hepatectomy liver failure. Owing to the regenerative capacity of the liver, preoperative portal vein embolization (PVE) has been proposed to increase the functional mass of the non-embolized liver segments that will remain in situ after surgery. However, in some patients, hypertrophy of the non-embolized liver segments following PVE is insufficient to support major hepatectomy. Several studies have demonstrated alternative techniques for inducing hypertrophy of the non-embolized liver segments, including PVE in conjunction with hepatic arterial embolization or hepatic vein embolization in conjunction with PVE. Investigation of new techniques for inducing hypertrophy of the future liver remnant can reasonably be expected to expand the selection criteria for extensive hepatic resection.
AuthorsGi-Young Ko, Shin Hwang, Kyu-Bo Sung, Dong-Il Gwon, Sung-Gyu Lee
JournalJournal of hepato-biliary-pancreatic sciences (J Hepatobiliary Pancreat Sci) Vol. 17 Issue 4 Pg. 410-2 (Jul 2010) ISSN: 1868-6982 [Electronic] Japan
PMID19890603 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents
Topics
  • Antineoplastic Agents (administration & dosage)
  • Carcinoma, Hepatocellular (therapy)
  • Chemoembolization, Therapeutic (methods)
  • Hepatic Veins
  • Humans
  • Hypertrophy (chemically induced, pathology)
  • Injections, Intravenous
  • Liver (drug effects, pathology)
  • Liver Neoplasms (therapy)
  • Portal Vein
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: